
Accurate imaging. Targeted therapy. Personalised cancer care.
Using safe, low-dose radiopharmaceuticals, nuclear medicine detects cancer early and supports precise, tailored treatment. At OncoCare Malaysia, advanced PET/CT and SPECT/CT technology at Thomson Hospital Kota Damansara delivers clarity, safety, and confidence in every scan.
Nuclear medicine is a medical specialty that uses radiopharmaceuticals to visualise, diagnose, and sometimes treat cancer. These substances emit low-level radiation that can be detected by advanced scanners such as PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography).
Unlike conventional imaging like CT or MRI, nuclear medicine shows how the body functions — not just its structure — allowing for earlier and more accurate cancer detection.


Radiopharmaceuticals are administered either through an injection, inhalation, or orally, depending on the procedure.
After administration, patients rest briefly before undergoing the scan. The procedure is safe, and radiation exposure is minimal — typically less than that from a standard CT scan.

Most nuclear medicine procedures are painless and well-tolerated.
Side effects are rare, and patients can usually return to normal activities soon after.
Our care team provides clear guidance before and after your procedure and ensures your comfort at every step.
Your oncologist or nuclear medicine specialist reviews your case and recommends suitable scans or therapies.
You’ll receive instructions on fasting or medication adjustments, if needed.
Radiopharmaceutical is administered and imaging or therapy performed.
Your results are analysed and discussed with your oncologist.
Additional imaging may be scheduled to monitor progress.

Yes. The radiation exposure is very low and comparable to routine diagnostic imaging. All procedures are conducted under strict safety standards.
A CT scan shows body structures, while a PET scan shows how cells are functioning. Combined PET/CT imaging provides comprehensive diagnostic insight.
Yes. Specific treatments, such as radioactive iodine therapy or Lutetium-177 therapy, target cancer cells directly while sparing healthy tissue.
Typically 1–2 hours, depending on the type of scan and preparation required.